Episode Details

Back to Episodes

Stocks at Fresh 13-Month Highs as Investors Eye the Fed, and Biogen’s Latest Boardroom Drama 6/13/23

Published 2 years, 9 months ago
Description

Markets added to the week’s gains, with the S&P and Nasdaq both closing at their highest levels since last April. The Dow at its best since February 13. But will tomorrow’s Fed decision take the air out of the rally? Plus a shake up on Biogen’s board raising eyebrows as the company’s Alzheimer’s treatment draws questions. What it all means for the stock.

 

Fast Money Disclaimer

 

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us